Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer

NCT04784910 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

423

Enrollment

INDUSTRY

Sponsor class

Conditions

Peptic Ulcer

Interventions

DRUG: DWP14012 20mg
DRUG: Lansoprazole 15 mg
DRUG: DWP14012 20mg placebo
DRUG: Lansoprazole 15 mg placebo

Sponsor

Daewoong Pharmaceutical Co. LTD.